Kenota is poised to disrupt the allergy diagnostic market with the introduction of a point- of-care testing system that dramatically enhances the speed, convenience and accuracy of allergy testing. Our development centre is in Kitchener, Ontario Canada where we are building our future success based on the talent, energy and commitment of over 35 team members. We've raised $11M to date from top investors including Y Combinator, Draper, OS Fund and allergy specialists.